Literature DB >> 17082481

Targeting of metallothionein by L-homocysteine: a novel mechanism for disruption of zinc and redox homeostasis.

John C Barbato1, Otilia Catanescu, Kelsey Murray, Patricia M DiBello, Donald W Jacobsen.   

Abstract

OBJECTIVE: L-homocysteine and/or L-homocystine interact in vivo with albumin and other extracellular proteins by forming mixed-disulfide conjugates. Because of its extremely rich cysteine content, we hypothesized that metallothionein, a ubiquitous intracellular zinc-chaperone and superoxide anion radical scavenger, reacts with L-homocysteine and that homocysteinylated-metallothionein suffers loss of function. METHODS AND
RESULTS: 35S-homocysteinylated-metallothionein was resolved in lysates of cultured human aortic endothelial cells in the absence and presence of reduced glutathione by SDS-PAGE and identified by Western blotting and phosphorimaging. Using zinc-Sepharose chromatography, L-homocysteine was shown to impair the zinc-binding capacity of metallothionein even in the presence of reduced glutathione. L-Homocysteine induced a dose-dependent increase in intracellular free zinc in zinquin-loaded human aortic endothelial cells within 30 minutes, followed by the appearance of early growth response protein-1 within 60 minutes. In addition, intracellular reactive oxygen species dramatically increased 6 hours after L-homocysteine treatment. In vitro studies demonstrated that L-homocysteine is a potent inhibitor of the superoxide anion radical scavenging ability of metallothionein.
CONCLUSIONS: These studies provide the first evidence that L-homocysteine targets intracellular metallothionein by forming a mixed-disulfide conjugate and that loss of function occurs after homocysteinylation. The data support a novel mechanism for disruption of zinc and redox homeostasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082481      PMCID: PMC2849140          DOI: 10.1161/01.ATV.0000251536.49581.8a

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  44 in total

Review 1.  Egr-1 is a major vascular pathogenic transcription factor in atherosclerosis and restenosis.

Authors:  Florian Blaschke; Dennis Bruemmer; Ronald E Law
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

2.  Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice.

Authors:  J Zhou; J Møller; C C Danielsen; J Bentzon; H B Ravn; R C Austin; E Falk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-09       Impact factor: 8.311

3.  Cardiac performance in inbred rat genetic models of low and high running capacity.

Authors:  J Chen; G M Feller; J C Barbato; S Periyasamy; Z J Xie; L G Koch; J I Shapiro; S L Britton
Journal:  J Physiol       Date:  2001-09-01       Impact factor: 5.182

4.  Homocysteine binds to human plasma fibronectin and inhibits its interaction with fibrin.

Authors:  Alana K Majors; Shantanu Sengupta; Belinda Willard; Michael T Kinter; Reed E Pyeritz; Donald W Jacobsen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-08-01       Impact factor: 8.311

Review 5.  Influence of hyperhomocysteinemia on the cellular redox state--impact on homocysteine-induced endothelial dysfunction.

Authors:  Norbert Weiss; Stanley J Heydrick; Otilia Postea; Christiane Keller; John F Keaney; Joseph Loscalzo
Journal:  Clin Chem Lab Med       Date:  2003-11       Impact factor: 3.694

6.  In vitro and in vivo interactions of homocysteine with human plasma transthyretin.

Authors:  Amareth Lim; Shantanu Sengupta; Mark E McComb; Roger Théberge; William G Wilson; Catherine E Costello; Donald W Jacobsen
Journal:  J Biol Chem       Date:  2003-09-24       Impact factor: 5.157

7.  Metallothionein protects islets from hypoxia and extends islet graft survival by scavenging most kinds of reactive oxygen species.

Authors:  Xiaoyan Li; Hainan Chen; Paul N Epstein
Journal:  J Biol Chem       Date:  2003-10-23       Impact factor: 5.157

8.  Association of multiple cellular stress pathways with accelerated atherosclerosis in hyperhomocysteinemic apolipoprotein E-deficient mice.

Authors:  Ji Zhou; Geoff H Werstuck; Sárka Lhoták; A B Lawrence de Koning; Sudesh K Sood; Gazi S Hossain; Jan Møller; Merel Ritskes-Hoitinga; Erling Falk; Sanjana Dayal; Steven R Lentz; Richard C Austin
Journal:  Circulation       Date:  2004-06-21       Impact factor: 29.690

9.  Metallothionein can function as a chaperone for zinc uptake transport into prostate and liver mitochondria.

Authors:  Leslie C Costello; Zhixin Guan; Renty B Franklin; Pei Feng
Journal:  J Inorg Biochem       Date:  2004-04       Impact factor: 4.155

10.  Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation.

Authors:  Hong Wang; XiaoHua Jiang; Fan Yang; John W Gaubatz; Lang Ma; Mark J Magera; XiaoFeng Yang; Peter B Berger; William Durante; Henry J Pownall; Andrew I Schafer
Journal:  Blood       Date:  2002-12-27       Impact factor: 22.113

View more
  20 in total

1.  Incrimination of heterogeneous nuclear ribonucleoprotein E1 (hnRNP-E1) as a candidate sensor of physiological folate deficiency.

Authors:  Ying-Sheng Tang; Rehana A Khan; Yonghua Zhang; Suhong Xiao; Mu Wang; Deborah K Hansen; Hiremagalur N Jayaram; Aśok C Antony
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Cellular zinc and redox buffering capacity of metallothionein/thionein in health and disease.

Authors:  Wolfgang Maret; Artur Krezel
Journal:  Mol Med       Date:  2007 Jul-Aug       Impact factor: 6.354

3.  Ly6C+ Inflammatory Monocyte Differentiation Partially Mediates Hyperhomocysteinemia-Induced Vascular Dysfunction in Type 2 Diabetic db/db Mice.

Authors:  Pu Fang 方璞; Xinyuan Li 李欣源; Huimin Shan 单慧敏; Jason J Saredy; Ramon Cueto; Jixiang Xia 夏继祥; Xiaohua Jiang 蒋晓华; Xiao-Feng Yang 杨晓峰; Hong Wang 王虹
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-01       Impact factor: 8.311

4.  Vitamin B12 protects against superoxide-induced cell injury in human aortic endothelial cells.

Authors:  Edward S Moreira; Nicola E Brasch; June Yun
Journal:  Free Radic Biol Med       Date:  2011-06-02       Impact factor: 7.376

5.  Influence of +1245 A/G MT1A polymorphism on advanced glycation end-products (AGEs) in elderly: effect of zinc supplementation.

Authors:  Robertina Giacconi; Andreas Simm; Alexander Navarrete Santos; Laura Costarelli; Marco Malavolta; Patrizia Mecocci; Francesco Piacenza; Andrea Basso; Tamas Fulop; Lothar Rink; George Dedoussis; Stavroula Kanoni; Georges Herbein; Jolanta Jajte; Eugenio Mocchegiani
Journal:  Genes Nutr       Date:  2014-08-23       Impact factor: 5.523

Review 6.  Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets.

Authors:  Yi Fu; Xian Wang; Wei Kong
Journal:  Br J Pharmacol       Date:  2017-09-22       Impact factor: 8.739

Review 7.  Molecular targeting of proteins by L-homocysteine: mechanistic implications for vascular disease.

Authors:  Alla V Glushchenko; Donald W Jacobsen
Journal:  Antioxid Redox Signal       Date:  2007-11       Impact factor: 8.401

8.  Zinc-gene interaction related to inflammatory/immune response in ageing.

Authors:  Eugenio Mocchegiani; Marco Malavolta
Journal:  Genes Nutr       Date:  2008-07       Impact factor: 5.523

Review 9.  Association of methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism with autism: evidence of genetic susceptibility.

Authors:  Vandana Rai
Journal:  Metab Brain Dis       Date:  2016-03-08       Impact factor: 3.584

10.  Metallothionein 1 Overexpression Does Not Protect Against Mitochondrial Disease Pathology in Ndufs4 Knockout Mice.

Authors:  Hayley Christy Miller; Roan Louw; Michelle Mereis; Gerda Venter; John-Drew Boshoff; Liesel Mienie; Mari van Reenen; Marianne Venter; Jeremie Zander Lindeque; Adán Domínguez-Martínez; Albert Quintana; Francois Hendrikus van der Westhuizen
Journal:  Mol Neurobiol       Date:  2020-09-11       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.